<DOC>
	<DOCNO>NCT02511561</DOCNO>
	<brief_summary>This 1-month , multicenter , open-label study subject unilateral otitis externa . Eligible subject receive single dose 6 mg OTO-201 affect ear . The study design characterize safety , procedural factor clinical effect OTO-201 administer subject otitis externa .</brief_summary>
	<brief_title>OTO-201 Treatment Otitis Externa</brief_title>
	<detailed_description />
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Externa</mesh_term>
	<mesh_term>Ciprofloxacin</mesh_term>
	<criteria>Inclusion Criteria include , limited : Subject male female age 6 month 80 year , inclusive Subject clinical diagnosis unilateral otitis externa Subject subject 's caregiver willing comply protocol attend study visit Exclusion Criteria include , limited : Subject tympanic membrane perforation Subject history know immunodeficiency disease Subject fungal otitis externa , base clinical sign</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Otitis externa</keyword>
	<keyword>Swimmer 's ear</keyword>
	<keyword>Ear infection</keyword>
</DOC>